相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Efficacy and safety of omalizumab in Chinese patients with anti-histamine refractory chronic spontaneous urticaria
Weiru Yuan et al.
DERMATOLOGIC THERAPY (2022)
Experience of the first 1127 COVID-19 Vaccine Allergy Safety patients in Hong Kong-Clinical outcomes, barriers to vaccination, and urgency for reform
Valerie Chiang et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2022)
Updated consensus statements on COVID-19 Vaccine Allergy Safety in Hong Kong
Valerie Chiang et al.
ASIA PACIFIC ALLERGY (2022)
The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Torsten Zuberbier et al.
ALLERGY (2022)
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity
Mark W. Tenforde et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Forewarned is forearmed: chronic spontaneous urticaria as a potential risk to effective SARS-CoV-2 vaccine uptake and global public health
W. H. Bermingham et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
Consensus Statements on the Approach to COVID-19 Vaccine Allergy Safety in Hong Kong
Valerie Chiang et al.
FRONTIERS IN ALLERGY (2021)
Factors Associated with Self-Reported Drug Allergies in a Large Chronic Spontaneous Urticaria Cohort
Christine Rauscher et al.
CURRENT DRUG SAFETY (2021)
Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020
Marcus Maurer et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2020)
Classification of hypersensitivity reactions
Melanie C. Dispenza
ALLERGY AND ASTHMA PROCEEDINGS (2019)
Epidemiology and comorbidities of patients with chronic urticaria in Korea: A nationwide population-based study
Bo Ri Kim et al.
JOURNAL OF DERMATOLOGY (2018)
Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE-CSU
G. Sussman et al.
ALLERGY (2018)
The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
T. Zuberbier et al.
ALLERGY (2018)
Cost-effectiveness of omalizumab for the treatment of chronic spontaneous urticaria
T. A. Kanters et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Cyclosporine for Chronic Spontaneous Urticaria: A Meta-Analysis and Systematic Review
Kanokvalai Kulthanan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)
Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria
Hide Michihiro et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2017)
The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSU
M. Maurer et al.
ALLERGY (2017)
Analysis of disease activity categories in chronic spontaneous/idiopathic urticaria
D. Stull et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review
J. Bradford Rice et al.
CLINICAL THERAPEUTICS (2017)
Corticosteroid-related toxicity in patients with chronic idiopathic urticaria-chronic spontaneous urticaria
Dennis Ledford et al.
ALLERGY AND ASTHMA PROCEEDINGS (2016)
Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials
Zuo-Tao Zhao et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
BSACI guideline for the management of chronic urticaria and angioedema
R. J. Powell et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2015)
Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H-1 Antihistamines: A Randomized, Placebo-Controlled Study
Sarbjit S. Saini et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Chronic urticaria in Chinese population: a hospital-based multicenter epidemiological study
H. Zhong et al.
ALLERGY (2014)
Adherence to best practice guidelines in chronic spontaneous urticaria (CSU) improves patient outcome
Niall P. Conlon et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2014)
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy
Allen Kaplan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report
M. Maurer et al.
ALLERGY (2011)
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria
Sarbjit Saini et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Risk of first-generation H1-antihistamines: a GA2LEN position paper
M. K. Church et al.
ALLERGY (2010)
Development of a daily diary for patients with chronic idiopathic urticaria
Susan D. Mathias et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2010)
How to assess disease activity in patients with chronic urticaria?
A. Mlynek et al.
ALLERGY (2008)
Chronic idiopathic urticaria: prevalence and clinical course
Kanokvalai Kulthanan et al.
JOURNAL OF DERMATOLOGY (2007)
Cyclosporine in chronic idiopathic urticaria: A double-blind, randomized, placebo-controlled trial
Gino A. Vena et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Cognitive and other adverse effects of diphenhydramine use in hospitalized older patients
JV Agostini et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Natural course of physical and chronic urticaria and angioedema in 220 patients
MMA Kozel et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2001)
Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria
CEH Grattan et al.
BRITISH JOURNAL OF DERMATOLOGY (2000)
Effects of fexofenadine, diphenhydramine, and alcohol on driving performance - A randomized, placebo-controlled trial in the Iowa Driving Simulator
JM Weiler et al.
ANNALS OF INTERNAL MEDICINE (2000)